Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate

Fig. 2

Calculated absorbed radiation dose rates in the tumour and kidney after 10 MBq 213Bi-DOTATATE, based on the data obtained in the biodistribution study. Absorbed dose rate as function of time in H69 tumour-bearing animals; tumour (a) and kidney (b). Same data are shown of the tumour (c) and kidney (d) for CA20948 tumour-bearing animals. Red lines indicate the absorbed dose rate contributed by all alpha particles and blue lines by all beta particles. The dotted lines indicate the individual absorbed dose rate of 213Bi, 213 Po, 209Tl and 209 Pb

Back to article page